RGEN
REPLIGEN CORP
+4.46 (+2.58%)177.37USD301K成交股數10.0B市值239.7本益比(近四季)12.8股價營收比+11.9%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 204M+21% | 194M+16% | 189M+22% | 182M+15% | 169M+10% | 168M+19% | 155M-3% | 159M-4% | 153M | 141M | 159M | 165M |
| 營業成本 | 94.1M | 86.0M | 88.3M | 89.4M | 77.8M | 129M | 77.4M | 77.3M | 76.4M | 105M | 79.3M | 81.8M |
| 毛利 | 110M+20% | 108M+179% | 101M+30% | 93.0M+14% | 91.4M+19% | 38.8M+6% | 77.5M-3% | 81.5M-2% | 76.8M | 36.6M | 79.9M | 83.5M |
| 毛利率 | 53.9% | 55.7% | 53.2% | 51.0% | 54.0% | 23.2% | 50.0% | 51.3% | 50.1% | 25.9% | 50.2% | 50.5% |
| 研發費用 | 14.4M | 14.5M | 14.2M | 14.0M | 12.1M | 11.7M | 9.7M | 10.6M | 11.2M | 10.6M | 9.7M | 12.2M |
| 銷售管理費用 | 76.6M | 76.5M | 73.7M | 70.9M | 70.7M | 60.5M | 75.6M | 65.5M | 61.8M | 55.6M | 49.1M | 56.3M |
| 營業利益 | 14.0M+112% | 15.9M-144% | 16.8M-315% | 13.9M+154% | 6.6M+75% | −36.5M-878% | −7.8M-141% | 5.5M-61% | 3.8M | 4.7M | 19.3M | 13.9M |
| 營業利益率 | 6.8% | 8.2% | 8.9% | 7.6% | 3.9% | -21.8% | -5.1% | 3.4% | 2.4% | 3.3% | 12.1% | 8.4% |
| 稅後淨利 | 5.0M-14% | 8.3M-125% | 14.9M-2380% | 14.9M+160% | 5.8M+77% | −33.9M-300% | −654K-103% | 5.7M-63% | 3.3M | 16.9M | 19.8M | 15.3M |
| 淨利率 | 2.5% | 4.3% | 7.9% | 8.2% | 3.4% | -20.2% | -0.4% | 3.6% | 2.2% | 12.0% | 12.4% | 9.3% |
| 稀釋 EPS | 0.09-10% | 0.15-125% | 0.26-2700% | 0.26+160% | 0.10+67% | -0.61-303% | -0.01-103% | 0.10-63% | 0.06 | 0.30 | 0.35 | 0.27 |
| 稀釋股數 | 56.6M | 56.7M | 56.5K | 56.5M | 56.6M | 55.9K | 56.0K | 56.4K | 56.5K | 56.9K | 56.9K | 57.0K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 607M | 583M | 749M | 709M | 697M | 757M | 784M | 809M | 781M | 631M | 604M | 517M |
| 應收帳款 | 158M | 152M | 149M | 157M | 147M | 134M | 129M | 123M | 116M | 106M | 120M | 133M |
| 存貨 | 187M | 179M | 160M | 156M | 153M | 143M | 182M | 191M | 198M | 211M | 241M | 245M |
| 總資產 | 3.0B | 2.9B | 2.9B | 2.9B | 2.9B | 2.8B | 2.8B | 2.9B | 2.9B | 2.5B | 2.6B | 2.5B |
| 有息負債 | 551M | 547M | 538M | – | – | 526M | – | – | – | – | – | – |
| 總負債 | 838M | 825M | 841M | 840M | 867M | 857M | 814M | 882M | 888M | 549M | 600M | 621M |
| 股東權益 | 2.1B | 2.1B | 2.1B | 2.1B | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B | 1.9B |
| 負債比 | 28.4% | 28.2% | 28.8% | 28.9% | 30.4% | 30.3% | 28.8% | 30.8% | 31.1% | 21.8% | 23.5% | 24.4% |
| 淨現金(現金 − 有息負債) | 55.7M | 36.1M | 211M | – | – | 232M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 28.3M | – | – | 15.0M-66% | – | – | – | 44.7M | – | – | 11.2M |
| 資本支出 | – | 4.7M | – | – | 3.6M | – | – | – | 8.3M | – | – | 8.5M |
| 自由現金流 | – | 23.6M | – | – | 11.4M-69% | – | – | – | 36.4M | – | – | 2.6M |
| 折舊攤銷 | – | 19.8M | – | – | 18.7M | – | – | – | 16.9M | – | – | 15.4M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 12.1% | – | – | 6.8% | – | – | – | 23.7% | – | – | 1.6% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 1.5B
| 產品 | 738M | 50.0% | +16.4% |
|---|---|---|---|
| Filtration Products | 403M | 27.3% | +8.0% |
| Chromatography Products | 153M | 10.4% | +24.7% |
| Proteins Products | 97.4M | 6.6% | +30.9% |
| Process Analytics Products | 81.2M | 5.5% | +37.0% |
| Other Products | 3.3M | 0.2% | -29.0% |
| Royalty | 296K | 0.0% | +13.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 738M | +16.4% | 48.9M | 6.6% | 0.86 | 93.9M |
| FY2024 | 634M | +0.3% | −25.5M | -4.0% | -0.46 | 150M |
| FY2023 | 632M | -21.1% | 35.6M | 5.6% | 0.63 | 77.7M |
| FY2022 | 802M | +19.5% | 186M | 23.2% | 3.24 | 87.2M |
| FY2021 | 671M | +83.1% | 128M | 19.1% | 2.24 | 51.9M |
| FY2020 | 366M | +35.5% | 59.9M | 16.4% | 1.11 | 40.2M |
| FY2019 | 270M | +39.3% | 21.4M | 7.9% | 0.44 | 48.7M |
| FY2018 | 194M | – | 16.6M | 8.6% | 0.37 | 22.1M |